Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Sleeve Gastrectomy Improves LV Systolic Function

By HospiMedica International staff writers
Posted on 18 May 2016
Sleeve gastrectomy improves left ventricular (LV) systolic function in both men and women, according to a new study.

Researchers at Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital (Istanbul, Turkey) conducted a study in 53 obese patients referred for sleeve gastrectomy to evaluate and compare the effects of weight lost after the procedure on left ventricular (LV) systolic function, using both two-dimensional speckle tracking (2D-STE) and three-dimensional echocardiography (3DE) prior to and six months after surgery.

The results showed that all patients demonstrated a significant decrease in body mass index (BMI), body weight, blood pressure, heart rate, LV end-diastolic dimension, myocardial wall thickness, LV mass, LV mass index, LV mass/height2.7, LV end-diastolic and -systolic volume, and stroke volume (SV) at six months after surgery. More...
There was no significant difference in measured variables between men and women, except for baseline LV end-diastolic dimension, and baseline and after surgery LV mass, LV mass index, and LV mass/height2.7, which were all significantly higher in men. The study was published early online on April 27, 2016, in the Journal of Clinical Ultrasound.

“Sleeve gastrectomy improves LV systolic function and contributes to reverse LV remodeling in both genders,” concluded lead author Tuğba Kemaloğlu Öz, MD, and colleagues.

Sleeve gastrectomy is a restrictive form of weight loss surgery intended for the morbidly obese, which permanently reduces the size of the stomach by removing the lateral 2/3 of the stomach with a stapling device. While the stomach is drastically reduced in size, function is preserved, with no malabsorption of nutrients and supplements. The procedure avoids the problems associated with bypass forms of weight loss surgery including anemia, intestinal obstruction or blockage, osteoporosis, and protein and vitamin deficiency, and since about 100-200 ml of stomach capacity is maintained, there are very few restrictions on food consumption.

Dividing LV mass by height to the allometric power of 2.7 is the most promising normalization method in terms of practicality and usefulness from a clinical and scientific standpoint for scaling myocardial mass to body size.

Related Links:
Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.